ArticleLeukemia & lymphoma2015

A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia.

Jonathan How et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.